Literature DB >> 16122255

A novel method for the synthesis of imidazo[5,1-f][1,2,4]triazin-4(3H)-ones.

Alexander Heim-Riether1, Jason Healy.   

Abstract

[reaction: see text] Imidazo[5,1-f][1,2,4]triazinones, as isosteres of purine, are of interest for pharmaceutical research. The syntheses reported in the literature generally require several steps. We report a novel method to access a broad range of diversely substituted derivatives. The key step is the electrophilic N-amination of 3H-imidazoles containing a 4-carbonyl group. Several different substituted imidazoles have been N-aminated in this manner. The resulting N-aminoimidazoles were cyclized under different conditions to the corresponding imidazotriazinones, which allowed for additional diversification. This novel method was applied in a formal synthesis of vardenafil, a well-known representative of this class of compounds. Furthermore, we report the first synthesis of a 7-aryl-imidazotriazinone via bromination of an unsubstituted imidazotriazinone followed by a Suzuki coupling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16122255     DOI: 10.1021/jo051014w

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  3 in total

1.  Development of 2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of aldehyde dehydrogenase 1A (ALDH1A) as potential adjuncts to ovarian cancer chemotherapy.

Authors:  Brandt C Huddle; Edward Grimley; Mikhail Chtcherbinine; Cameron D Buchman; Cyrus Takahashi; Bikash Debnath; Stacy C McGonigal; Shuai Mao; Siwei Li; Jeremy Felton; Shu Pan; Bo Wen; Duxin Sun; Nouri Neamati; Ronald J Buckanovich; Thomas D Hurley; Scott D Larsen
Journal:  Eur J Med Chem       Date:  2020-12-03       Impact factor: 6.514

Review 2.  An overview of the synthetic routes to the best selling drugs containing 6-membered heterocycles.

Authors:  Marcus Baumann; Ian R Baxendale
Journal:  Beilstein J Org Chem       Date:  2013-10-30       Impact factor: 2.883

3.  Late-Stage Microsomal Oxidation Reduces Drug-Drug Interaction and Identifies Phosphodiesterase 2A Inhibitor PF-06815189.

Authors:  Antonia F Stepan; Tuan P Tran; Christopher J Helal; Maria S Brown; Cheng Chang; Rebecca E O'Connor; Michael De Vivo; Shawn D Doran; Ethan L Fisher; Stephen Jenkinson; David Karanian; Bethany L Kormos; Raman Sharma; Gregory S Walker; Ann S Wright; Edward X Yang; Michael A Brodney; Travis T Wager; Patrick R Verhoest; R Scott Obach
Journal:  ACS Med Chem Lett       Date:  2018-01-04       Impact factor: 4.345

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.